Wednesday, October 17, 2012 5:18 PM
|
CCSVI in Multiple Sclerosis
“To date, no disease modifying drugs for MS that have gained licensed approval for specifically improving or reducing disability in MS,” adds Prof. Tremlett, who is also a member of the Brain Research Centre at UBC and VCH Research Institute. This research study received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. Some MS patients experience “natural” improvements in disability: UBC-VCH researchwww.publicaffairs.ubc.ca Multiple sclerosis (MS) patients sometimes experience “natural” improvements in disability at least over the short term, according to a new study led by researchers at the University of British Columbia and Vancouver Coastal Health Research Institute.
|